#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Germ cell cancer Congenital aplastic anaemia Gaucher's disease type I Intracranial calcification Mantle cell lymphoma stage II Pancreatic carcinoma Myocarditis Cold type haemolytic anaemia Congenital absence of bile ducts Non-Hodgkin's lymphoma refractory Thrombocytopenia Trigeminal neuralgia Toxic epidermal necrolysis Breast angiosarcoma metastatic Ventricular fibrillation More trials…

    Learn about Rare Diseases

    Combined immunodeficiency – Trials in Disease Propionic acidaemia – Trials in Disease Angiosarcoma – Basic Information Mucopolysaccharidosis III – Treatment Mucopolysaccharidosis – Basic Information Chronic granulomatous disease – Trials in Disease Lymphatic malformation – Life with Disease Primary biliary cholangitis – Diagnostics Hereditary motor and sensory neuropathy – Treatment Systemic sclerosis pulmonary – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Namilumab Natalizumab Rocatinlimab Nemtabrutinib ROC-101 HYDROCHLORIDE Alnuctamab Calcitriol Sulfamethoxazole Protamine Sulfate Ulotaront Levobupivacaine Hydrochloride Tumour Detection Casirivimab Fostemsavir Trometamol Aluminium Oxide Vosilasarm ORG-129 Exenatide AB521 Tildacerfont More therapies…

    Learn about Your Condition

    End stage renal disease Conjunctivitis allergic Lymphocyte adoptive therapy Skin angiosarcoma Type IIa hyperlipidaemia Dedifferentiated liposarcoma Dry eye Viral infection Juvenile psoriatic arthritis Mite allergy Petit mal epilepsy Testicular germ cell cancer Aphthous ulcer Type V hyperlipidaemia Adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hypertriglyceridaemia

  • Study of Plozasiran to prevent acute pancreatitis in adults with severe hypertriglyceridemia

    Recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Austria Belgium Bulgaria Croatia Czechia Hungary +6

  • Long-Term Safety Study of Plozasiran for Adults with High Triglycerides

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia France Germany +8

  • Study of Plozasiran for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Belgium Bulgaria Croatia Czechia Hungary Italy +4

  • Study on Plozasiran and ARO-APOC3 for Adults with Severe Hypertriglyceridemia

    Not recruiting

    3 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Latvia +4

  • Study to Evaluate Plozasiran for Adults with High Triglycerides

    Not recruiting

    3 1
    Investigated Drugs:
    • Synthetic Double-Stranded Sirna Oligonucleotide Directed Against Apolipoprotein C-Iii Mrna And Covalently Linked To A Ligand Containing Three N-Acetylgalactosamine Residues
    Bulgaria Czechia France Germany Hungary Italy +3

  • Study on the Safety of A24110He for Patients with Type 2 Diabetes and High Triglycerides

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Hypertriglyceridaemia
    Investigated Drugs:
    • A24110He
    • Human Albumin Solution
    • Insulin Human (Rdna)
    Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!